No Association of RNF213 Polymorphism with Reversible Cerebral Vasoconstriction Syndrome

참고문헌 (10)

1. Singhal AB, "Reversible cerebral vasoconstriction syndromes : analysis of 139 cases", Arch Neurol, 68, pp.1005~1012 (2011)
2. Chen SP, "Recurrence of reversible cerebral vasoconstriction syndrome : a long-term follow-up study", Neurology, 84, pp.1552~1558 (2015)
3. Choi HA, "Characteristics and demographics of reversible cerebral vasoconstriction syndrome : a large prospective series of Korean patients", Cephalalgia, 38, pp.765~775 (2018)
4. 방오영, "The Pathophysiology of Moyamoya Disease: An Update", 대한뇌졸중영문학회지, 18(1), pp.12~20 (2016), 대한뇌졸중학회
5. Jong S. Kim, "RNF213 Polymorphism in Intracranial Artery Dissection", 대한뇌졸중영문학회지, 20(3), pp.404~406 (2018), 대한뇌졸중학회
6. Bang OY, "A polymorphism in RNF213 is a susceptibility gene for intracranial atherosclerosis", PLoS One, 11, pp.e0156607~ (2016)
7. Lee MJ, "Blood-brain barrier breakdown in reversible cerebral vasoconstriction syndrome : implications for pathophysiology and diagnosis", Ann Neurol, 81, pp.454~466 (2017)
8. Headache Classification Committee of the International Headache Society, "The International Classification of Headache Disorders, 3rd edition (beta version)", Cephalalgia, 33, pp.629~808 (2013)
9. Choi HA, "Cerebral endothelial dysfunction in reversible cerebral vasoconstriction syndrome : a case-control study", J Headache Pain, 18, pp.29~ (2017)
10. World Drug Report 2019, "United Nations Office on Drugs and Crime", United Nations publication, ~ (2019)

관련 논문AI추천